Treatment for rare genetic disorder added to PBS
An Australian-developed therapy to treat hereditary angioedema (or H-A-E) is now part of the Pharmaceutical Benefits Scheme. H-A-E is a rare and chronic condition found in one in 50,000 Australians who experience unpredictable swelling in abdomen, larynx, face, and limbs, and the condition is life-threatening. The new treatment called Andembry is applied once a month …
Treatment for rare genetic disorder added to PBS Read More »